Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Badger Meter Inc (BMI) vs Boston Scientific Corporation (BSX) Price & Performance

Badger Meter IncTrade
Boston Scientific CorporationTrade

Price performance (Past 24H)

Key statistics

Badger Meter Inc vs Boston Scientific Corporation — how do they compare? Badger Meter Inc trades at $132.67 (market cap $3.93B), while Boston Scientific Corporation trades at $50.72 (market cap $74.19B). The key difference: Boston Scientific Corporation is far larger — about 18.9× Badger Meter Inc's market cap, and Badger Meter Inc pays a 1.18% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.

BMIBSX
Market Cap
$3.93B$74.19B
Sector
TechnologyHealth
52-Week High
$193.09$108.14
52-Week Low
$113.41$42.63
Enterprise Value
$3.84B$86.27B
Dividend Yield
1.18%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Badger Meter Inc

No Aura AI signal available yet.

Boston Scientific Corporation

BSX trades at $50.46, up 2.33% today, with strong earnings beats in recent quarters and a bullish technical trend. Revenue grew to $20.07B in 2025, with net income margin expanding to 17.5%. The stock shows robust institutional support and insider buying, while facing near-term headwinds from competitive pressures in key segments like WATCHMAN.

Outlook remains positive with 86% analyst buy ratings and a $67.21 consensus price target, implying 33% upside. Risks include guidance cuts and market share losses, but solid cash flow and valuation metrics support long-term growth potential for patient investors.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Badger Meter Inc

Badger Meter provides industry-leading water management solutions. Its smart measurement hardware and software analytics help water utilities and industrial customers optimize operations and conserve natural resources.

Read more on BMI

About Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Read more on BSX